
Please try another search
By Davit Kirakosyan
Morgan Stanley downgraded Five9, Inc (NASDAQ:FIVN) to Equalweight from Overweight. Shares plummeted more than 25% intra-day today after the company’s CEO announced his resignation.
Guggenheim downgraded Bristol-Myers Squibb Co. (NYSE:BMY) to Neutral from Buy. While the company’s overall clinical and regulatory execution in 2022 has been solid with three new drug approvals (Opdualag, Camzyos, and Sotyktu), the analysts believe the path to reaping the rewards will be longer and more challenging than what is currently reflected in the Street estimates.
Goldman Sachs downgraded Procter & Gamble Company (NYSE:PG) to Neutral from Buy. “Relative valuation levels for Staples are daunting; now even richer than the onset of the last recession,” commented the analysts there.
Ford Motor Company (NYSE:F) shares dropped more than 6% intra-day today after UBS downgraded the company to Sell from Neutral and lowered its price target to $10.00 from $13.00, noting that the risk to earnings and free cash flow is “under-estimated.”
UBS downgraded General Motors (NYSE:GM) to Neutral from Buy and lowered its price target to $38.00 from $56.00. As a result, shares fell nearly 4% intra-day today. While the analysts continue to like the company's EV momentum in 2023 with a strong (IRA-compliant) launch pipeline, they believe the overall sector outlook for 2023 is deteriorating fast so demand destruction seems inevitable at a time when supply is improving. The analysts expect EPS to more than halve next year.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.